Generic Name: Ropinirole
Requip® XL™ is indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. It is an extended-release, once-daily tablet formulation that provides continuous delivery of ropinirole over 24 hours to provide smooth blood levels.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat Parkinson's | 127 |
|
|
|
|
41 | |
| tremor | 10 |
|
|
3 | |||
| Stiffness/Spasticity | 6 |
|
|
3 | |||
| Mobility | 5 |
|
|
3 | |||
| Other | 3 |
|
|
2 | |||
| Support another treatment | 3 | 0 |
See all 171 patients currently taking Requip XL
Mouse over the table for more information
Top 10 dosages based on patients currently taking Requip XL. See all 20 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
14 | 54% |
|
|
Doctor's advice
|
7 | 27% |
|
|
Did not seem to work
|
5 | 19% |
|
|
Expense
|
4 | 15% |
|
|
Other
|
4 | 15% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 24, 2009.